Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial-Reference-Cited by-同舟云学术

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

Published:2001-11 Issue:9293 Volume:358 Page:1576-1585
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Neoptolemos JP,Dunn JA,Stocken DD,Almond J,Link K,Beger H,Bassi C,Falconi M,Pederzoli P,Dervenis C,Fernandez-Cruz L,Lacaine F,Pap A,Spooner D,Kerr DJ,Friess H,Büchler MW

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Incidence, treatment and survival in 13,560 patients with pancreatic cancer: an epidemiological study in the West Midlands;Bramhall;Br J Surg,1995

2. Cancer Research Campaign, Factsheet 9.3: Survival–England and Wales,1988

3. Cancer incidence in five continents, vol VI;Parkin,1992

4. Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving?;Nitecki;Ann Surg,1995

5. Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: UK survey of specialist pancreatic units;Neoptolemos;Br J Surg,1997

Cited by 961 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant and Adjuvant Therapy in Resectable Pancreatic Adenocarcinoma;Surgical Clinics of North America;2024-10

2. Implication of Capillary Morphogenesis Gene 2 (CMG2) in the Disease Progression and Peritoneal Metastasis of Pancreatic Cancer;Cancers;2024-08-20

3. Update on management of pancreatic cancer: a literature review;Chinese Clinical Oncology;2024-06

4. Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how;World Journal of Gastrointestinal Surgery;2024-05-27

5. Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma;Hong Kong Medical Journal;2024-04-09